Skip to main content

Table 6 R0 resection rates

From: Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for stage II–IVa esophageal cancer: a network meta-analysis

Back to article page

Systematic Reviews

ISSN: 2046-4053